Table 5.
Name | Ligand | Structure | Ionicity | Renal excretion | ||
---|---|---|---|---|---|---|
(Elimination T½; hours — near complete elimination in 6 T½) | ||||||
Normal RF | Moderately reduced RF | Severely reduced RF | ||||
(eGFR > 60 mL/min) | (eGFR 30–60 mL/min) | (eGFR < 30 mL/min) | ||||
Gadopentetate | DTPA | Linear | Ionic | 1.6 | 4.0 | 30.0 |
Gadodiamide | DTPA-BMA | Linear | Nonionic | 1.3 | NA | 27.4 |
Gadobenate | BOPTA | Linear | Ionic | 1.2–2.0 | 5.6 | 9.2 |
Gadoxetate | EOB-DTPA | Linear | Ionic | 1.0 | 2.2 | 20.0 |
Gadoteridol | HP-DO3A | Macrocyclic | Nonionic | 1.6 | 6.9 | 9.5 |
Gadobutrol | BT-DO3A | Macrocyclic | Nonionic | 1.8 | 5.8 | 17.6 |
Gadoterate | DOTA | Macrocyclic | Ionic | 1.6 | 5.1 | 13.9 |
Gadopiclenol | Piclen | Macrocyclic | Nonionic | 1.6–1.9 | 3.8 | 11.7 |
NA, no data available; RF, renal function; eGFR, estimated glomerular filtration rate; T½, half-life
Sources: see references in text